Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.957,48
-0,18%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Ampio Pharmaceuticals Inc (AMPE) Ampio Pharmaceuticals Inc (AMPE) Notizie

AMPE

Ampio Pharmaceuticals (AMPE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:AMPE
DataOraFonteTitoloSimboloCompagnia
03/04/202420:33PR Newswire (US)Ampio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationAMEX:AMPEAmpio Pharmaceuticals Inc
25/03/202422:00PR Newswire (US)Ampio Announces Voluntary Delisting and SEC DeregistrationAMEX:AMPEAmpio Pharmaceuticals Inc
05/03/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202421:49Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202421:48Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202421:46Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202421:45Edgar (US Regulatory)Form RW - Registration Withdrawal RequestAMEX:AMPEAmpio Pharmaceuticals Inc
14/02/202423:45PR Newswire (US)Ampio Provides Update on Results from Pre-IND Enabling StudiesAMEX:AMPEAmpio Pharmaceuticals Inc
25/01/202422:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AMPEAmpio Pharmaceuticals Inc
11/01/202422:15PR Newswire (US)Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal ActionsAMEX:AMPEAmpio Pharmaceuticals Inc
21/12/202322:25Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
14/11/202322:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AMPEAmpio Pharmaceuticals Inc
31/10/202314:00PR Newswire (US)Ampio Pharmaceuticals to Present at the Emerging Growth ConferenceAMEX:AMPEAmpio Pharmaceuticals Inc
05/10/202322:30PR Newswire (US)Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201AMEX:AMPEAmpio Pharmaceuticals Inc
18/09/202322:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
31/08/202312:30PR Newswire (US)Ampio Pharmaceuticals Announces Reverse Stock SplitAMEX:AMPEAmpio Pharmaceuticals Inc
15/08/202322:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AMPEAmpio Pharmaceuticals Inc
13/07/202317:33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AMPEAmpio Pharmaceuticals Inc
14/06/202323:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AMPEAmpio Pharmaceuticals Inc
09/06/202320:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AMPEAmpio Pharmaceuticals Inc
26/05/202322:40Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AMPEAmpio Pharmaceuticals Inc
26/05/202322:40PR Newswire (US)Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common StockAMEX:AMPEAmpio Pharmaceuticals Inc
08/05/202322:54Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AMPEAmpio Pharmaceuticals Inc
28/04/202323:14Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:AMPEAmpio Pharmaceuticals Inc
18/04/202312:30PR Newswire (US)AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERSAMEX:AMPEAmpio Pharmaceuticals Inc
27/03/202322:43Edgar (US Regulatory)Annual Report (10-k)AMEX:AMPEAmpio Pharmaceuticals Inc
02/02/202318:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:AMPEAmpio Pharmaceuticals Inc
27/12/202223:44PR Newswire (US)Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsAMEX:AMPEAmpio Pharmaceuticals Inc
17/11/202222:53PR Newswire (US)Ampio Pharmaceuticals Announces NYSE American Removal of Trading SuspensionAMEX:AMPEAmpio Pharmaceuticals Inc
08/11/202222:30PR Newswire (US)Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock SplitAMEX:AMPEAmpio Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:AMPE

La tua Cronologia

BTHB
MATICKRW
Polygon
ASX
GMAKOR
BIT
PSGQHD
Pharus Sicav Global Valu...
LBNK
YEONUSDT
YEON
BIT
P1AJ27
BNP Paribas Issuance
BIT
P117U5
Bnp Paribas Issuance
BOV
FRRN3B
Rumo Malha Norte ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network